Alex Wiltschko

So the kind of the big version of this that's happening in the UK is called the UK Biobank.

In the US, it's called All of Us.

And the idea is pretty simple.

I mean, the scientists like me like to gussied up with different words, but it's like, let's go fishing.

Let's collect everything that we can possibly collect.

And then maybe we can sort out something that's valuable after we do that for a long while.

Scent could become the new breath, but we need to do some bioprospecting.

We need a Framingham study equivalent for scent.

That hasn't been done.

And it's reasonable because the cost of analyzing a scent sample, or even in some ways how to even do it in the first place, the cost is high and how to do it's not that well established.

We've largely fixed the cost problem by building this company and kind of solving the problems we've had to solve.

And I think over time we'll solve the sampling problem.

And what's missing, frankly, is a nation state, that's the level, or an extremely wealthy individual or group of individuals to say, we want to do better than blood.

We don't want to have to stick a needle in young people or in old people.

And we also want our answers almost instantly.

And so we have to use not the molecules circulating in the liquids inside of us, but the molecules that are always escaping through our skin.

We want to tap into that.

We know that air is data and we just call that smell.

That's the tag that we use for the data that's in the air that we detect.

Why don't we go start to collect a database of that?